Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

Therapeutic Solutions Utilizes MSC Exosomes to Suppress Inflammatory Pathologies

October 18, 2021 By Cade Hildreth (CEO) Leave a Comment

Therapeutic Solutions International Utilizes Mesenchymal Stem Cell Exosomes to Effectively Suppress Neutrophil Extracellular Trap Production
Patent Filed on Potential Solution to Cause of Major Inflammatory Pathologies

ELK CITY, Idaho, Oct. 4, 2021 — Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced laboratory data demonstrating that exosomes produced by JadiCells™, the Company’s Phase III cell therapy candidate for COVID-19 and other lung pathology, as well as mesenchymal stem cells proprietary to the Company, can suppress the production of neutrophil extracellular traps. [Read more…]

Stem Cell Fillings Replace The Need For Root Canal Procedure

September 16, 2021 By Marie Carroll 1 Comment

Those who live in fear of the infamous root canal – maligned worldwide for its painful nature and disliked for the fact that it kills the tooth – will find relief in the news that researchers have found a promising alternative in the form of stem cell fillings. This approach relies on treating root causes and conditions (no pun intended) rather than treating surface symptoms. The goal of regenerative medicine? To return former functionality to the body – in this case, the tooth.

The goal behind stem cell fillings is to repair the tooth as though the damage had never occurred. Of course, this approach raises many questions. How is it different than a root canal? Where do you get the stem cells? Are there risks involved? The goal of this article is to answer these questions. [Read more…]

Meet the New York Scientist Using Stem Cells as a Treatment For MS

September 6, 2021 By Cade Hildreth (CEO) 8 Comments

Treatment for multiple sclerosis (MS) is an evolving area and one in which new therapeutic approaches are rapidly advancing. Led by Dr. Saud Sadiq, the Tisch MS Research Center of New York is pursuing a Phase II clinical trial exploring the use of stem cell technology for the treatment for MS. The announcement followed positive results from an FDA-approved Phase I stem cell trial for MS. [Read more…]

MSCs as an Appealing Raw Material for Use in Regenerative Medicine

June 17, 2021 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal stem cells (MSCs) are a type of non-controversial, adult stem cell that prefers to differentiate into the specialized cells found in skeletal tissues, such as cartilage cells (chondrocytes), bone cells (osteoblasts), and fat cells (adipocytes). In contrast, stem cells derived from embryos are capable of developing into all the different types of cells found in our body, which makes them more versatile than MSCs, but also more controversial. Induced pluripotent stem cells also exhibit greater pluripotency, but as modified cells, they come with a greater set of regulatory challenges. [Read more…]

RoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium

May 21, 2021 By Cade Hildreth (CEO) Leave a Comment

RoosterGEM™, a complete genetic engineering medium, empowers product developers to realize up to four-fold increased transduction efficiency in primary cells, and achieve a greater than 50% reduction in overall gene transfer cost.

Frederick, MD, May 20, 2021 – RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product developers, today announced the launch of its product RoosterGEM™, a stand-alone, complete gene transfer medium that is optimized to remove key challenges in primary cell genetic modification. [Read more…]